Issue No.: 3 / 2013
Original Contributions
165|
Reviews
173|
177|
182|
Original Contributions
187|
Reviews
194|
201|
204|
209|
214|
Case Reports
218|
224|
227|
231|
Journal selection
Display all journals
Most read
- Practice guideline and trends for immunosuppressive treatment of glomerulonephritides according to KDIGO (Clinical Practice Guideline for Glomerulonephritis) | views: 164
- Current opinions on gout, its diagnosis and treatment | views: 126
- Aortic regurgitation | views: 116
- Targeted therapeuticts and their role in the treatment of internal diseases | views: 90
- Opinion of the Czech Atherosclerosis Society‘s committee (CSAT) on the ESC/EAS guidlines related to the diagnostics and treatment of dyslipidemias issued in 2011 | views: 90
- Outcomes of Catheter Ablation of Atrial Fibrillation in Patients over 65 Years of Age | views: 82
- Treatment of AL amyloidosis in 2012; the benefit of new drugs (bortezomib, thalidomide, and lenalidomide). Summary of published clinical trials | views: 82
- Risk factors for relapsing and severe Clostridium difficile infection | views: 78
- Ischemic peripheral arterial disease and recurrent iliofemoral venous thrombosis in a 24-year-old man with antiphospholipid syndrome | views: 77
- Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic – BIBY-I study (observations lasting 3 to 12 months) | views: 46